Drugs / Temocillin
Temocillin
also known as
BRL 17421 [AS SODIUM] · BRL 17421 FREE ACID · BRL-17421 · NEGABAN · Temocilina · Temocilline
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 34 trials | ||||||
| Phase 3 | NCT07631364 | Sep 2026 → Oct 2028 expected | gonorrhea | Assistance Publique - Hôpitaux de Paris | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05565222 | Mar 2023 → Apr 2026 | infectious disease with sepsis | Assistance Publique - Hôpitaux de Paris | Unknown | No outcome recorded |
| Phase 3 | NCT04478721 | Dec 2020 → Dec 2024 | bacterial infectious disease | Andalusian Public Foundation for Health Research in Seville | Completed | No outcome recorded |
| Phase 3 | NCT03543436 | Jan 2019 → Oct 2020 | bacterial urinary tract infection | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT02959957 | May 2016 → Aug 2019 | urinary tract infection | Håkan Hanberger | Completed | No outcome recorded |
| Phase 4 | NCT02681263 | Apr 2016 → Apr 2018 | urinary tract infection | University Hospital, Grenoble | Unknown | No outcome recorded |
| Phase 4 | NCT01543347 | Feb → Nov 2012 | urinary tract infection | Belpharma s.a. | Withdrawn | No outcome recorded |
| Phase 4 | NCT02285075 | Jun 2011 → Dec 2014 | end stage renal failure, gram-negative bacterial infections | AZ Sint-Jan AV | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03557840 | Apr 2019 → Apr 2023 | bacterial infectious disease | Paul M. Tulkens | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02260102 Comparator | Feb 2016 → Dec 2022 | liver disorder, urinary tract infection | Catholic University of Louvain | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | temocillin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02285075 ↗ |
| Known as | BRL 17421 [AS SODIUM] | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276310 ↗ |
| Known as | BRL 17421 FREE ACID | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276310 ↗ |
| Known as | BRL-17421 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276310 ↗ |
| Known as | NEGABAN | “Temocillin (NEGABAN®) 2 g intravenous with lidocaine (3ml)” NCT07631364 ↗ |
| Known as | Temocilina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276310 ↗ |
| Known as | Temocilline | ChEMBL registry synonym — accepted as the source's own label CHEMBL1276310 ↗ |
| Modality | Small molecule | “Temocillin is a renally cleared penicillin” NCT02285075 ↗ |
| Route | Intravenous | “administered by IV route” NCT02260102 ↗ |